医药临床护理Musculardiseasesppt课件

上传人:沈*** 文档编号:200743201 上传时间:2023-04-17 格式:PPT 页数:68 大小:771KB
收藏 版权申诉 举报 下载
医药临床护理Musculardiseasesppt课件_第1页
第1页 / 共68页
医药临床护理Musculardiseasesppt课件_第2页
第2页 / 共68页
医药临床护理Musculardiseasesppt课件_第3页
第3页 / 共68页
资源描述:

《医药临床护理Musculardiseasesppt课件》由会员分享,可在线阅读,更多相关《医药临床护理Musculardiseasesppt课件(68页珍藏版)》请在装配图网上搜索。

1、MusculardiseasesMyastheniagravisDefinition:Myastheniagravisiscausedbyadefectofneuromusculartransmissionduetoanantibody-mediatedattackuponnicotinicacetylcholinereceptors(AChR).ClinicalCharacter:FluctuatingweaknessImprovedbyinhibitorsofcholinesteraseEtiologyandPathogenesisRelatedtodestructiveeffectsof

2、autoantibodiestoAChREvidence:1.Experimental immunization of animalswith purified AChR from an electric fish,induces high titers of antibody to thereceptor.2.HumanserumantibodiesthatreactwithhumanAChRwerefoundinMGpatients3.Electrophysiologic features of MG wereproducedbypassivetransferofhumanIgGtomic

3、e.4.Plasmapheresisreducedplasmalevelsofanti-AChR and ameliorated myasthenicsymptomsandsigns.Howtheautoimmunedisorderstartsisnotknown.InhumanMG,hyperplasiaofthethymusabout15%ofcasesisathymoma.AChRantibodiesaresynthesizedbyBcellofhyperplasticthymusgland.Whenhumanmyasthenicthymuswastransplantedintomice

4、,theanimalproducedantibodiestoAChRthatboundtotheirownmotorend-plates.A.Primarilyinthethymus.1.70%ofthymusglandfromadultMGpatientsarenotinvoluted.2.Thethymusweighmorethannormal.3.The thymus glands show lymphoidhyperplasia.4.Immunocytochemical:germinalcenterscontainBcells,plasmacells,andTcells.Patholo

5、gy5.10%of myasthenic thymus glandscontainthymomas.B.Loss of synaptic folds and widenedcleftsC.Somenerveterminalsaresmallerthannormal.D.On residual synaptic folds show Y-shapedantibody-likestructures,IgG.Clinicalfeatures1.Incidence:0.4/100,000.Prevalence:5/100,000.Beforeage40,Male:female3:12.Symptoms

6、:Threeclinicalcharacteristics.1)Thefluctuatingnature:Theweaknessvaries in a single day;day to day;or overlongerperiods.(remissionsorexacerbations).Crisis:When an exacerbation involvesrespiratorymuscles2)Thedistributionofweakness:A.Ocularmusclesareaffectedfirstinabout40%ofthecases(Ptosisanddiplopia).

7、B.Affected facial oropharyngeal muscles(dysarthria,dysphagia and limination offacialmovements).C.Limbandneckweakness.Crisis:occurin:oropharyngealrespiratorymuscleweakness.provokedby:respiratoryinfectionsurgicalproceduresemotionalstresssystemicillness3).Thethirdcharacteristicistheclinical response to

8、 cholinergicdrugs.Thisoccurssouniformlythatithasbecomepartofthedefinition.3.Signs:(1)The vital signs and general physicalexamination are normal limits,unless thepatientisincrisis.(2)Weakness of the facial and levatorpalpabraemusclesproducesacharacteristicexpressionlessfaceswithdroopingeyelids.(3).Co

9、mpleteophthalmoplegiainoneorbotheyes(diplopia).Thepupilisneverinvolved.(4).Weakness of oropharyngeal or limbmuscles,andrespiratorymuscle.(5).Sensationisnormalandthereflexesarepreserved.1.Classification:(1)Group1.About14%ofpatientshaveocularmyastheniaonly.(2)GroupIIA.Mildgeneralizedmyastheniawithocul

10、arsigns.(3)Group IIB.Moderately severe generalizedmyasthenia,with mild bulbar and ocularinvolvement.(4)Group III.Acute severe myasthenia,withbulbarandrespiratory complications.Tracheostomyisrequired.(5)GroupIV.Lateseveremyasthenia,usuallydevelopingfromothergroupswithin2years.1.Routineexaminationsofb

11、lood,urine,andCSFarenormal.2.EMG:90%patients have progressivedecrementintheamplitudeofmuscleactionpotentialsevokedbyrepetitivenervestimulationat3to5Hz.Laboratorytests3.AchRAntibodiestoarefoundin90%ofpatientsofallages.Thetiterdosenotmatchtheseverityofsymptoms.4.CTscansofthemediastinumdemonstrates thy

12、momas,especially inthoseolderthan40.Diagnosis1.Characteristichistoryandphysicalexamination.2.Jollytest3.Edrophonium(Tension)tests.4.Neostigminetest:0.04mg/kg,IM,reachesitsmaximum activity in 1-2 hours.Theeffectisgoneat3-4hours.5.EMG.6.AntibotiestoAchRtest.7.CT scans of thymus.Hyperplasia orthymoma.D

13、ifferentialdiagnosis:1.Botulism:presynapticblockerofacetylcholinereleasecausedbycontaminatefoodsprogressivemuscleweaknessBeginning:extraocularpharyngealmusclesTreatment:trivalentantitoxinguanidinehydrochloride2.Lambert-Eatonsyndrome(LEMS):Myasthenia-likesyndromeoccurswithcarcinomaGeneralizedmusclewe

14、aknessThe EMG is helpful in differentiating thesyndromefromtruemyastheniagravis.Treatment with removal of the tumor andguanidinehydrochloride.Treatment1.Anticholinesterasetherapy:Anticholinesterase drug should be given assoonasthediagnosisismade.i.Pyridostigmine60mgqidii.Neostigminebromide15mgqidiii

15、.Ifthepatientshavedifficultyeating,dosescanbetakenabout30minutesbeforeameal.2.Corticosteroidtherapy(1).High-dosecoticosteroidtherapy1).Prednisone,60-100mgdaily.Improvementbeginsatabout12days.2).Dexamethasone,20mgdailyIVfor10days.3).Prednisononmethel,480-1000mgdailyIVfor3-5days.(2).Low-dosecorticoste

16、roidtherapy:prednisone25mg,qod,graduallyincreasingthedosageby12.5mgeveryweekuntilthetotal dosage reaches 100 mg on alternatedays.3.Immunotherapy(1).Azathioprine,50-100mg,twiceaday.(2).Cyclophophamide100mg,twiceaday.3.Thymectomy:About80%ofpatientswithoutthymomabecomeasymptomaticorgotocompleteremissio

17、nafterthymectomy.4.Plasmapheresis:Toremovetheharmfulantibody.6.Treatmentofcrisis(1).Myastheniccrisis:needassistedventilationabout10%ofmyasthenicpatientsoccur,occur in patients with dysarthria,dysphagia,respiratorymuscleweakness,respiratoryinfection,andmajorsurgerycausedbylessanticholinesterasedrugsd

18、osage.(2).Cholinergiccrisis:overdosageofanticholineserasedrugscholinergicsideeffects,excessiveanticholinesterasetherapy.(3).Brittlecrisis:Chronic anticholinergic drugs damages thesynapse,somepatientsbecomerefractorytothemedication.Crisisisanemergency.The patients respiratory function must bemaintain

19、edsameasrespiratoryfailuretreatmentCholinergicdrugdiscontinuedinafewdaysorweeks.The therapeutic goal is to maintain vitalfunctionsandtoavoidortreatinfection.3.DrugsofavoidedDrugsthathavemildneuromuscularblockingeffectsandsedatives,arecontraindicated.Quinine,Quinidine,Procainamide,Propranolol,Lidocai

20、ne,Aminoglycosideantibiotics,Polymyxin,Viomycin,Colistin,Morphine,Bubiurates,andothertranquilizers.8.Amongthetreatment,anticholinesterasegrugtherapyandplasmapheresisaresymptomatictreatmentsthymectomy,steroids,andotherimmunosuppressivedrugsmayalterthecourseofthedisease.Periodicparalysischaracterizedb

21、outsoflimbweakness.someformshavebeenmappedtothegeneforthe apha subunit of the sodium channel ofmuscleregardas“channelopathies.”Thetwomaintypeswerefirstseparatedbythelevelofserumpotassium.HypokalemicperiodicParalysisThe potassium content decreases in aspontaneousattacktovaluesof3.0mEq/Lorlower.Attack

22、smaybeinduced:injectonofinsulin,orglucose,ingestionofamealhighincarbohydrates.Incidence:Male:female,3:1autosomedominantheredityThefirstattackusuallyoccursatpuberty,butitmayoccurastheageof4ordelayedtothesixthdecade.SymptomsandSigns:attackusuallybeginsafterrest.Itcommonlydevelopsduringthenightparalysi

23、svariesfromslightweaknessofthelegtocompleteparalysisTheoropharyngealandrespiratorymusclesareusuallyspared.Theremayberetentionofurineandfecesduringasevereattack.Attackvariesfromafewhoursto24hours.Theintervalbetweenattacksmaybeoneyear,oroneormoreattacksmayoccurdaily.Weaknessisespeciallybepresentonthem

24、orningaftertheingestionofahigh-carbohydratemealbeforeretiringonthepreviousnight.Intervalbetweenattacks,patientsarestrongandserumpotassiumnormal.In a mild attack,tendon reflexes and electricalreactionsarediminished.Insevereattacks,tendonandcutaneousreflexesare absent and muscles do not respond toelec

25、tricalstimulation.Cutaneoussensationisnotdisturbed.Fatalities are rare,but death may occur fromrespiratoryparalysis.Diagnosis:transientattacksofweakness.confirmed by finding low potassium,highsodiumcontentintheserumduringanattack,orbyinducinganattackwithIVglucose(100g)andregularinsulin(20units).Trea

26、tment1.Acute attacks,rapidly terminated byingestionof20to100mEqofpotassiumsalts.Thebasisoftherapyisoraladministrationofacetazolamide,250to1000mgdaily.Thisregimenpreventsattacksinabout90%2.spironolactonepromoteretentionpotassium.Patientswiththyrotoxicperiodicparalysisarespontaneousorinducedattacksdur

27、ingtheperiodofhyperthyroidism.Glucoseandinsulinareusefulintheinterimbetweentreatmentofhyperthyroidismbydrugsorradioiodine,beforetheeuthyroidstatereturns.HyperkalemicPeriodicParalysisCharacterizedonsetbeforeage10attackstooccurinthedaytimeandtobeshorterandlesssevereMyotoniaisdemonstrablebyEMGMyotonic

28、lid-lag is the sole clinicalevidenceofthetrait.The serum and urinary potassium contentmaybeincreasedduringanattack,thismaybeduetoleakageofpotassiumfrommuscle.The attacks tend to be precipitated byhunger,rest,andcoldandbyadministrationofpotassiumchoride.Attacksmaybeterminatedbyadministrationofcalcium

29、gluconate,glucose,andinsulin.Acetazolamide,250 mg to 1000 mg daily,hasbeeneffectiveinreducingthenumberofattacksorinabolishingthemaltogether.ProgressiveMuscularDystrophiesDefinition:A muscular dystrophy has fiveessentialcharacteristics.1.defined by clinical,histologic,and EMGcriteria.No signs of dene

30、rvation or sensory loss,unlessthereisaconcommitantandseparatedisease.2.symptoms include limb or cranial muscleweakness.(Theheartandvisceralmusclesmayalsobeinvolved.)3.Symptomsbecomeprogressivelyworse.4.Histologicchangesimplydegenerationandregeneration of muscle,but no abnormalstorageofmetabolicprodu

31、ctisevident.5.This disease is recognized as heritable,even if there are no other cases in theparticularfamily.Classification.Therearefourmaintypes:Duchennemusculardystrophy(DMD)Facioscapulohumeralmusculardystrophy(FSHD)limb-girdlemusculardystrophy(LGMD)myotonicmusculardystrophyEachtypediffersfromthe

32、othersinageatonset,distributionofweakness,rateofprogression,presenceorabsenceofcalfhypertrophy,highserumlevelsofCK,andpatternofinheritance.LaboratoryDiagnosisEMGmusclebiopsyDNAanalysisSerumCKECGDuchenneMuscularDystrophyX-linkedrecessivetrait.Femalecarrythegenearecarriers.incidenceis1in3,500malebirth

33、s.nogeographic,ethnicvariation.onethirdarenewmutations;lifespanofDMDisshortened,about20-30y.prevalenceisless(1to18,000males).ClinicalFeatures1.Evident at birth if serum enzymes aremeasured.2.Thesymptomsdonotbeginuntilage3to5 years,but that may be a measure ininfants.3.Walkingdelayedandtheboysneverru

34、nnormally;Soon toe-walking and waddinggait.4.Progresses,overt difficulty walking,climbingstairs,andrisingfromchairs.5.An exaggerated lordosis is assumed tobalance.6.Theboystendtofalleasily,andtheyhavedifficultyrisingfromtheground.(Gowerssign)7.Asthediseaseprogresses:thearmsandhandsareaffectedswallow

35、ing,ocularmovementsaresparedIliotibialcontractureslimithipflexionheelcordcontracturescausetoe-walking8.Atage9-12,theboynolongerwalksandenters a wheelchair;scoliosis may becomeserious;contributetodisability.9.Byaboutage20,respirationiscompromised and mechanical ventilation isneeded.10.heartissparedcl

36、inically,butECGisabnormal:increasedR-Samplitude,anddeep,narrowQwaves.congestivefailuremaysuperveneinafewcases.gastrointestinalsystemissparedbutacutegastricdilatationinafewcases.MentalretardationaffectaboutonethirdofboyswithDMD.BeckerMuscularDystrophy(BMD)resemblesDMDinessentialcharacteristics:X-link

37、ed,calf hypertrophy,weakness isgreatestproximally,andserumCKlevelsarehigh.EMGandmusclehistologyaresame.Thetwodifferenceareageatonset(usuallyafterage12)andrateofprogression(stillwalkingafterage20,oftenlater).Diagnosis1.The clinical diagnosis of DMD is evident fromclinicalfeatures.In sporadic,atypical

38、 cases,spinal muscularatrophy might be mistake for DMD fasciculationand EMG denervation,identify the neurogenicdisorder.2.SerumCKlevelofDMDandBMDareusuallyatleast20timesnormal3.Dystrophingeneandproteinanalysiscanmakethecorrectdiagnosis.TreatmentThere is no specific drug therapy for DMDandBMD.Prednis

39、onetherapywasbetterthanplaceboincontrolledtrials.Bracingmaypreventscoliosisinwheelchair-boundpatients.Surgical correction of spinal and limbdeformitiestomaintainambulationaslongaspossible.Facioscapulohumeral(FSH)MuscularDystrophyautosomaldominantfashion.characteristicdistributionofweakness:thefaceis

40、alwaysaffected.Progressionisslow;evenbeasymptomatic.Onsetinadolesence,occasionallydetectedinchildren.Serumenzymelevelsarenormal.FSHDgenemapsto4q35-qter.ClinicalManifestations1.Facialweakness,Patientshaveneverbeenabletowhistleorblowupaballoon.2.Scapularwingingisprominent.3.The shoulder girdle has a c

41、haracteristicappearance.cannotraisethearmslaterallytoshoulderlevel.4.Weaknessinthelegsmayaffectproximalmuscles.Laboratorystudies:EMG and muscle biopsy show amyopathicpattern.Thehistologicchangesaremild.Serumenzymevaluesareusuallynormalortriviallyelevated.ECGisnormal.Diagnosis:Accordingtotheclinicalf

42、eatures,autosomaldominantfashion,serumCKlevel,andEMG.Management:Treatmentissymptomatic.Limb-GirdleMuscularDystrophy(LGMD)LGMDisamyopathicsyndromesofproximallimbweaknessthatareusuallyslowlyprogressive.Clinicalmanifestations1.Onsetinadolescenceoradult,andinheritance:autosomaldominantorrecessive.2.The

43、legs are usually affected first,withdifficultyclimbingstairsandrisingfromchairs.3.Awaddinggait.risingthearmsdifficult,andwingingofthescapula4.Kneejerkstendtolostbeforetheanklejerks.Cranial muscles are usually spared.Progressionisslow.5.EMGandmusclebiopsyshowmyopathicchanges.SerumCKmaybeelevatedbutlesssothaninDMD.Diagnosis:According to the clinical features andexclusiontoincludesyndromesthatdidnotmeetcriteriaforDMD,FSHD,ormyotoniccategorise.Management:Treatmentissymptomatic.同学们来学校和回家的路上要注意安全同学们来学校和回家的路上要注意安全

展开阅读全文
温馨提示:
1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
2: 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
3.本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 装配图网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
关于我们 - 网站声明 - 网站地图 - 资源地图 - 友情链接 - 网站客服 - 联系我们

copyright@ 2023-2025  zhuangpeitu.com 装配图网版权所有   联系电话:18123376007

备案号:ICP2024067431-1 川公网安备51140202000466号


本站为文档C2C交易模式,即用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。装配图网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知装配图网,我们立即给予删除!